Prime Health Probiotics for Children
Prime Health Probiotics for Children, NPN 80047164: natural health product licensed in Canada. Medicinal ingredients: Bifidobacterium longum subsp. infantis, Lactobacillus rhamnosus, Bifidobacterium breve, Lactobacillus fermentum.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium longum subsp. infantis Source : Cellule entière | 0.3 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 1.05 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : Cellule entière | 0.45 Milliards d'UFC | Not calculated |
| Lactobacillus fermentum Source : Cellule entière | 0.2 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Saveur d'orange, Dioxyde de silicium, Acide L-malique, Xylitol, Extrait de Levure, Saveur de framboise, Bouillon trypticase soja, Saveur de fraise, Sucre, Saveur de mûre, Maltodextrine, Saveur de citron, Sucralose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 4 years ; maximum: 9 years | 1 packet | 1 day |
Uses authorised in Canada
Source of probiotics. Provides live microorganisms that temporarily modify gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product.
- Précautions et mises en garde
If you have nausea, fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhoea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner.
Product record
- Other names
- Maple Health Probiotics for Children, Maple Leaf Probiotics for Children
- Licence holder
- Prime Health Ltd. (Canada Global Life Sciences)
- NPN or DIN-HM
- 80047164
- Status
- Active licence
- Licence date
- 12 December 2013
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80047164
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Prime Health Probiotics for Children (Prime Health Ltd. (Canada Global Life Sciences)): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80047164-prime-health-probiotics-for-children, updated 12 December 2013.